Erlmeier F, Zschäbitz S, Mikuteit M, Autenrieth M, Weichert W, Hartmann A, Steffens S (2023)
Publication Type: Journal article
Publication year: 2023
Book Volume: 38
Pages Range: 403-407
Journal Issue: 4
DOI: 10.14670/HH-18-520
BACKGROUND: The prognostic value of Claudin-6 (CLDN6) in non clear cell renal cell carcinoma (RCC) is still unclear. AIM: To evaluate the prognostic impact of CLDN6 expression in a large cohort of chromophobe RCC (chRCC). MATERIAL AND METHODS: Patients who underwent renal surgery due to chRCC were recruited. Clinical data were retrospectively evaluated. Tumor specimens were analyzed for CLDN6 expression by immunohistochemistry. RESULTS: 81 chRCC patients were eligible for analysis, thereof 10 (12.3%) patients were positive for CLDN6. No significant associations were found for CLDN6 expression and clinical attributes in patients with chRCC. Kaplan-Meier analysis revealed no differences in overall survival (OS) for patients with CLDN6⁻ compared to CLDN6⁺ tumors (87.0% versus 62.5%; p=0.174). CONCLUSION: In chRCC CLDN6 expression is not associated with parameters of aggressiveness or survival. Due to the rare incidence of chRCC further studies with larger cohorts are warranted.
APA:
Erlmeier, F., Zschäbitz, S., Mikuteit, M., Autenrieth, M., Weichert, W., Hartmann, A., & Steffens, S. (2023). The role of claudin-6 in chromophobe renal cell carcinoma. Histology and Histopathology, 38(4), 403-407. https://doi.org/10.14670/HH-18-520
MLA:
Erlmeier, Franziska, et al. "The role of claudin-6 in chromophobe renal cell carcinoma." Histology and Histopathology 38.4 (2023): 403-407.
BibTeX: Download